2011年1月26日星期三

Taiwan with oral cancer patients increase _ unity of rivers and Lakes

In Taiwan, oral cancer incidence increases every year, often one of the top 10 cancer middle-aged men, ages much better focus between 40 to 70 years old, men and women suffer from about 3:1, and age on a declining trend, clinically more young case for 20, 30 years old, showing oral cancer is no longer the old patent.����Occurrence of oral cancer, and likes to eat betel nuts about, if there are who eats betel nut and smoking and drinking, resulting in opportunities for oral cancer is 123 times times the average person. Early signs of oral cancer does not feel pain, bloody saliva may occasionally occur, it is not painful ulcers and painless lump is more terrible, often overlooked, missed opportunity for early detection. Taiwan increased from cancer in patients with oral squamous cell carcinoma-cancer health network, communication platform for cancer network-China's leading cancer tumors. Ginsenoside Rh2 with regard to the combination of medication and treatment of cancer, and their synergistic toxicity reduction function is very significant. Practice has shown that ginsenoside Rh2 with chemotherapy, synergy would serve as a drug, enhancing chemotherapy effects, reduce the side effects of chemotherapy drugs. And radiotherapy used together can counteract-Ray radiotherapy on peripheral blood cell damage, and enhance endurance in radiation therapy, radiotherapy full course to a successful conclusion. Ginsenoside Rh2 will also significantly enhance the body's immune function, can strengthen the patient's physical fitness and disease resistance, reducing the chances of infection, reduce the rate of cancer recurrence. In addition, studies have shown that ginsenoside Rh2 (effects of nurse) inhibits cancer cell growth in itself added value, through differentiation, direct inhibition of many cancer cells, and make it back to the evolution and transformation of normal cells, and finally complete cure of the disease the rehabilitation process. Oncologists inquiry hotline: 400-88-54321

没有评论:

发表评论